Evaluation of the synthesis of sialic Acid-PAMAM glycodendrimers without the use of sugar protecting Groups, and the Anti-HIV-1 properties of these compounds

Bioconjugate Chemistry

Volumn 22, Issue 10, 2011, Pages 2186-2197

  Clayton, Russell ^a   Hardman, Janee ^a   Labranche, Celia C ^b   McReynolds, Katherine D ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEINS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTI-HIV; ANTI-HIV ACTIVITY; CARBOXYL GROUPS; DIVERGENTS; GLYCODENDRIMERS; PROPERTY; PROTECTING GROUP; REACTION PATHWAYS; SIALIC ACIDS; SULPHATED DERIVATIVES;

CARBOXYLIC ACIDS;

GLYCOPROTEIN GP 120; POLYAMIDOAMINE; SIALIC ACID DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEASIBILITY STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; SUBSTITUTION REACTION; SULFATION; VIRUS INHIBITION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80054809927     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200331v     Document Type: Article

References (59)

1. UNAIDS (2010) pp 364, UNAIDS.
2. UNAIDS (2009) pp 100, UNAIDS.
3. Granich, R., Crowley, S., Vitoria, M., Lo, Y.-R., Souteyrand, Y., Dye, C., Gilks, C., Guerma, T., De Cock, K. M., and Williams, B. (2010) Highly active antiretroviral treatment for the prevention of HIV transmission J. Int. AIDS Soc. 13, 1-8
4. Broder, S. (2010) The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic Antiviral Res. 85, 1-18
5. Este, J. A. and Cihlar, T. (2010) Current status and challenges of antiretroviral research and therapy Antiviral Res. 85, 25-33
6. Hawkins, T. (2010) Understanding and managing the adverse effects of antiretroviral therapy Antiviral Res. 85, 201-209
7. Gupta, U. and Jain, N. K. (2010) Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting Adv. Drug. Delivery Rev. 62, 478-490
8. Ito, M., Baba, M., Sato, A., Pauwels, R., De Clerq, E., and Shigeta, S. (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro Antiviral Res. 7, 361-367 (Pubitemid 17101065)
9. Mitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., and Broder, S. (1988) Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells Science 240, 646-649
10. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., and De Clercq, E. (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro Proc. Natl. Acad. Sci. U.S.A. 85, 6132-6136
11. Callahan, L. N., Phelan, M., Mallinson, M., and Norcross, M. A. (1991) Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions J. Virol. 65, 1543-1550
12. Batinic, D. and Robey, F. A. (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides J. Biol. Chem. 267, 6664-6671
13. Meshcheryakova, D., Andreev, S., Taraswova, S., Sidorova, M., Vafina, M., Kornilaeva, G., Karamov, E., and Kaitov, R. (1993) CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments Mol. Immunol. 30, 993-1001
14. Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J. (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280, 1949-1953 (Pubitemid 28299405)
15. Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., and Sattentau, Q. J. (2000) Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120 J. Virol. 74, 1948-1960 (Pubitemid 30434054)
16. Bertozzi, C. R. and Kiessling, L. L. (2001) Chemical glycobiology Science 291, 2357-2364 (Pubitemid 32231790)
17. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2000) Synthetic multivalent ligands in the exploration of cell-surface interactions Curr. Opin. Chem. Biol. 4, 696-703
18. Roderiquez, G., Oravecz, T., Yanagishita, M., Bou-Habib, D. C., Mostowski, H., and Norcross, M. A. (1995) Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41 J. Virol. 69, 2233-2239
19. Yang, D.-W., Ohta, Y., Yamaguchi, S., Tsukada, Y., Haraguchi, Y., Hoshino, H., Amagai, H., and Kobayashi, I. (1996) Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type I in vitro Antiviral Res. 31, 95-104 (Pubitemid 26184462)
20. Lorentson, K. J., Hendrix, C. W., Collins, J. M., Kornhauser, D. M., Petty, B. G., Klecker, R. W., Flexner, C., Eckel, R. H., and Lietman, P. S. (1989) Dextran sulfate is poorly absorbed after oral administration Ann. Intern. Med. 111, 561-566 (Pubitemid 19244556)
21. Flexner, C., Barditch-Crovo, P. A., Kornhauser, D. M., Farzadegan, H., Nerhood, L. J., Chaisson, R. E., Bell, K. M., Lorentsen, K. J., Hendrix, C. W., Petty, B. G., and Lietman, P. S. (1991) Pharmacokinetics, Toxicity, and Activity of Intravenous Dextran Sulfate in Human Immunodeficiency Virus Infection Antimicrob. Agents Chemother. 35, 2544-2550
22. Hiebert, L. M., Wice, S. M., Jaques, L. B., Williams, K. E., and Conly, J. M. (1999) Orally administered dextran sulfate is absorbed in HIV-positive individuals J. Lab. Clin. Med. 133, 161-170 (Pubitemid 29073240)
23. McReynolds, K. D. and Gervay-Hague, J. (2007) Chemotherapeutic interventions targeting HIV interactions with host-associated carbohydrates Chem. Rev. 107, 1533-1552 (Pubitemid 46864970)
24. Tomalia, D. A., Baker, H., Dewald, J. R., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., and Smith, P. (1985) A new class of polymers: starburst-dendritic macromolecules Polymer J. (Tokyo) 17, 117-132
25. Kono, K., Kojima, C., Hayashi, N., Nishisaka, E., Kiura, K., Watarai, S., and Harada, A. (2008) Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin Biomaterials 29, 1664-1675
26. Fant, K., Esbjorner, E. K., Jenkins, A., Grossel, M. C., Lincoln, P., and Norden, B. (2010) Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity, and in vitro transfection efficiency Mol. Pharmaceutics 17, 1734-1746
27. Medina, S. H. and El-Sayed, M. E. H. (2009) Dendrimers as carriers for delivery of chemotherapeutic agents Chem. Rev. 109, 3141-3157
28. Rolland, O., Turrin, C.-O., Caminade, A.-M., and Majoral, J.-P. (2009) Dendrimers and nanomedicine: multivalency in action New J. Chem. 33, 1809-1824
29. Heegaard, P. M. H., Boas, U., and Sorensen, N. S. (2010) Dendrimers for vaccine and immunostimulatory uses. A review Bioconjugate Chem. 21, 405-418
30. Tekade, R. K., Kumar, P. V., and Jain, N. K. (2009) Dendrimers in oncology: an expanding horizon Chem. Rev. 109, 49-87
31. Labieniec, M. and Watala, C. (2009) PAMAM dendrimers-diverse biomedical applications. Facts and unresolved questions Cent. Eur. J. Biol. 4, 434-451
32. Jevprasesphant, R., Penny, J., Jalal, R., Attwood, D., MeKeown, N. B., and D'Emanuele, A. (2003) The influence of surface modification on the cytotoxicity of PAMAM dendrimers Int. J. Pharm. 252, 263-266 (Pubitemid 36126635)
33. Roy, R., Zanini, D., Meunier, S. J., and Romanowska, A. (1993) Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin J. Chem. Soc., Chem. Commun. 1869-1872 (Pubitemid 24026734)
34. Dimick, S. M., Powell, S. C., McMahon, S. A., Moothoo, D. N., Naismith, J. H., and Toone, E. J. (1999) On the meaning of affinity: cluster glycoside effects and concanavalin A J. Am. Chem. Soc. 121, 10286-10296 (Pubitemid 129541200)
35. Pohl, N. L. and Kiessling, L. L. (1999) Scope of multivalent ligand function. Lactose-bearing neoglycopolymers by ring-opening metathesis polymerization Synthesis Special Issue 1515-1519 (Pubitemid 29390165)
36. Wang, J.-Q., Chen, X., Zacharek, S., Chen, Y., and Wang, P. G. (1999) Enhanced inhibition of human anti-gal antibody binding to mammalian cells by synthetic ?-gal epitope polymers J. Am. Chem. Soc. 121, 8174-8181
37. Reuter, J. D., Myc, A., Hayes, M. M., Gan, Z., Roy, R., Qin, D., Yin, R., Piehler, L. T., Esfand, R., Tomalia, D. A., and Baker, J. R. (1999) Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers Bioconjugate Chem. 10, 271-278 (Pubitemid 29147731)
38. Woller, E. K. and Cloninger, M. J. (2001) The lectin-binding properties of six generations of mannose-functionalized dendrimers Org. Lett. 4, 7-10
39. Ashton, P. R., Hounsell, E. F., Jayaraman, N., Nilsen, T. M., Spencer, N., Stoddart, J. F., and Young, M. (1998) Synthesis and biological evaluation of ?- d -mannopyranoside-containing dendrimers J. Org. Chem. 63, 3429-3437 (Pubitemid 128500490)
40. Borges, A. R., Wieczorek, L., Johnson, B., Benesi, A. J., Brown, B. K., Kensinger, R. D., Krebs, F. C., Wigdahl, B., Blumenthal, R., Puri, A., McCutchan, F. E., Birx, D. L., Polonis, V. R., and Schengrund, C.-L. (2010) Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1 Virology 408, 80-88
41. Kensinger, R. D., Yowler, B. C., Benesi, A. J., and Schengrund, C.-L. (2004) Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120 Bioconjugate Chem. 15, 349-358 (Pubitemid 38365195)
42. Kensinger, R. D., Catalone, B. J., Krebs, F. C., Wigdahl, B., and Schengrund, C.-L. (2004) Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection Antimicrob. Agents Chemother. 48, 1614-1623 (Pubitemid 38544366)
43. Morales-Serna, J. A., Boutureira, O., Serra, A., Matheu, M. I., Diaz, Y., and Castillon, S. (2010) Synthesis of hyperbranched ?-galceramide-containing dendritic polymers that bind HIV-1 rgp120 Eur. J. Org. Chem. 2657-2660
44. Perez-Anes, A., Stefaniu, C., Moog, C., Majoral, J.-P., Blanzat, M., Turrin, C.-O., Caminade, A.-M., and Rico-Lattes, I. (2010) Multivalent catanionic galcer analogs derived from first generation dendrimeric phosphonic acids Bioorg. Med. Chem. 18, 242-248
45. Blanzat, M., Turrin, C.-O., Aubertin, A.-M., Couturier-Vida, C., Caminade, A.-M., Majoral, J.-P., Rico-Lattes, I., and Lattes, A. (2005) Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorous-containing dendrimers bearing Gal?1Cer analogs ChemBioChem 6, 2207-2213
46. Han, S., Baigude, H., Hattori, K., Yoshida, T., and Uryu, T. (2007) Synthesis of new spherical and hemispherical oligosaccharides with polylysine core scaffold Carbohydr. Poly. 68, 26-34 (Pubitemid 46204863)
47. Han, S., Yoshida, D., Kanamoto, T., Nakashima, H., Uryu, T., and Yoshida, T. (2010) Sulfated oligosaccharide cluster with polylysine core scaffold as a new anti-HIV dendrimer Carbohydr. Poly. 80, 1111-1115
48. Tabarani, G., Reina, J. J., Ebel, C., Vives, C., Lortat-Jacobs, H., Rojo, J., and Fieschi, F. (2006) Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding FEBS Lett. 580, 2402-2408 (Pubitemid 44389366)
49. Konou, M., Koizumi, M., Shimizu, K., Kawase, M., and Hatanaka, K. (2000) Synthesis of sulfated colominic acids and their interaction with fibroblast growth factors Biomacromolecules 1, 451-458
50. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., Bilska, M., Kothe, D. L., Salazar-Gonzalez, J. F., Wei, X., Decker, J. M., Hahn, B. H., and Montefiori, D. C. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies J. Virol. 79, 10108-10125 (Pubitemid 41098552)
51. Montefiori, D. C. (2009) Measuring HIV neutralization in a luciferase reporter gene assay, in HIV protocols, 2nd ed. (Prasad, V. R. and Kalpana, G. V., Eds.) pp 395-404, Humana Press, New York.
52. Suhara, Y., Kurihara, M., Kittaka, A., and Ichikawa, Y. (2006) Efficient synthesis of carbopeptoid oligomers: insight into mimicry of beta-peptide Tetrahedron 62, 8207-8217
53. Sigma-Aldrich Product Information Sheet, Dextran Sulfate, D8906. http://www.sigmaaldrich.com/catalog/Lookup.do?D7=0&N17=2&N16= AND(CONTEXT:1,OR(LOCATION:US,LOCATION:0))&N3=mode%20matchpartialmax&N5= All&N4=dextran%20sulfate&N1=S-ID&ST=RS&QS=ON&N25=0&F=TD (accessed 08/30/11).
54. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., Komarova, N. L., Nowak, M. A., Hahn, B. H., Kwong, P. D., and Shaw, G. M. (2003) Antibody neutralization and escape by HIV-1 Nature 422, 307-312 (Pubitemid 36378357)
55. Louder, M. K., Sambor, A., Chertova, E., Hunte, T., Barrett, S., Ojong, F., Sanders-Buell, E., Zolla-Pazner, S., McCutchan, F. E., Roser, J. D., Gabuzda, D., Lifson, J. D., and Mascola, J. R. (2005) HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity Virology 339, 226-238 (Pubitemid 41169790)
56. Seaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., Bhattacharya, T., Lapedes, A., Polonis, V. R., McCutchan, F. E., Gilbert, P. B., Self, S. G., Korber, B. T., Montefiori, D. C., and Mascola, J. R. (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies J. Virol. 84, 1439-1452
57. Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., and Subramaniam, S. (2008) Molecular architecture of native HIV-1 gp120 trimers Nature 455, 109-113
58. Devarakonda, B., Hill, R. A., and de Villiers, M. M. (2004) The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine Int. J. Pharm. 284, 133-140 (Pubitemid 39349146)
59. McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., and Holan, G. (2005) Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention Mol. Pharmaceutics 2, 312-318 (Pubitemid 41186407)